Man in UK Neuralink Trial Says Brain Chip ‘Feels Magical’ and Brings New Hope

One of the first people in the UK to receive Elon Musk’s Neuralink brain implant has described the experience as “magical”, saying the technology has given him renewed hope and could transform life for people with severe paralysis.

Sebastian Gomez-Pena, a volunteer in the UK’s first trial of the Neuralink device, said the implant has been life-changing since an accident left him paralysed from the neck down.

“It’s a massive change in your life when you suddenly can’t move any of your limbs,” he said. “This kind of technology gives you a new piece of hope.”

Seb was studying medicine when the accident happened. He is now one of seven participants in the UK safety and reliability trial.

The Neuralink chip, connected to 1,024 electrodes implanted in his brain, was fitted during a five-hour operation at University College London Hospital. The procedure involved British surgeons and Neuralink engineers, with the electrodes inserted by the company’s specialised robotic system designed to place microscopic threads into delicate brain tissue.

The electrodes were positioned around four millimetres into the part of Seb’s brain that controls hand movement. Signals from his brain are transmitted through ultra-thin threads to the chip, which sends data wirelessly to a computer. Artificial intelligence software then learns to interpret those signals, allowing Seb to control a cursor on a screen simply by thinking about moving his hand or fingers.

“When I think about moving my hand, it’s amazing to see that something actually happens,” he said. “You just think it and it does it.”

During a demonstration, Seb navigates his laptop with ease, opening files, highlighting text and scrolling through documents as smoothly as someone using a mouse or trackpad.

The neurosurgeon leading the UK trial, Mr Harith Akram, said the level of control achieved so far is remarkable.

“It’s mind-blowing to see how much control he has,” he said, adding that the technology could become a “game-changer” for people with severe neurological disabilities who currently have very limited options to regain independence.

Neuralink’s technology has taken nearly a decade to develop, combining advanced implants, surgical robotics and AI systems. The first human implant took place in the US two years ago, and a total of 21 people across the US, Canada, the UK and the UAE have now received the device. All participants have severe paralysis caused by spinal injuries, strokes or neurodegenerative conditions such as ALS.

While results from the trials have not yet been published in peer-reviewed journals or submitted to regulators, early indications are encouraging. Some users can already type on virtual keyboards by thought alone, while others have used robotic arms to feed themselves.

In addition to restoring movement, other trials are exploring whether similar implants could help people regain speech after stroke or brain injury. The company has also outlined longer-term ambitions, including research into restoring vision and even allowing users to control humanoid robots remotely.

Despite its promise, experts caution that larger and longer trials are still needed to prove the technology’s safety, reliability and long-term benefits before it can be approved for widespread use.

For now, progress depends on volunteers like Seb, whose determination is helping to push the boundaries of what brain-computer technology might one day achieve.